SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Apr 4, 2014
Document Date
May 16, 2014
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Print Page
RSS Feeds
E-Mail Alerts
Contact IR